Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 11:05 a.m.

    📋 INSMED INCORPORATED (INSM) - Financial Results

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 07:00:36

    Event Type: Financial Results

    Event Details:

    Insmed Inc (INSM) Reports Q4 2025 Financial Results Insmed Inc (INSM) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 29365
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 334764
      • Anticipated in the First Half of 2026
      • expected in the first half of 2026
      • targeting Stargardt disease is currently advancing toward the clinic, with an IND filing expected in the first half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Selling General Administrative 118.93K 488.68K $-369.75K -75.66%
    Operating Expenses Interest Expense 21.05K 63.20K $-42.14K -66.68%
    Operating Expenses Net Loss 220.52K 948.29K $-727.77K -76.75%
    Current Assets Prepaid Expenses Other Current Assets 65.60K 37.24K $28.35K +76.12%
    Current Assets Operating Lease Right Of Use Assets 10.71K 17.26K $-6.55K -37.95%
    Current Assets Other Assets 91.61K 93.23K $-1.61K -1.73%
    Current Liabilities Operating Lease Liabilities 4.13K 9.36K $-5.22K -55.83%
    Current Liabilities Other Long Term Liabilities 5.59K 499.00 $5.10K +1021.24%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Insmed Inc
    • CIK: 0001104506
    • Ticker Symbol: INSM
    • Period End Date: 2025-10-30
    • Document Type: 8-K

Search

News categories